Na-Eun Kim | Immunotherapy | Best Researcher Award

Published on by Biotechnology Scientist

Best Researcher Award

Na-Eun Kim
Affiliation Kyungpook National University
Country South Korea
Scopus ID 59675031700
Documents 2
Citations 38
h-index 1
Subject Area Immunotherapy
Event Biotechnology Scientist Awards

Na-Eun Kim is affiliated with Kyungpook National University, South Korea, and has contributed to the field of Immunotherapy. The available bibliometric indicators indexed by Scopus report two scholarly publications, thirty-eight citations, and an h-index of one, reflecting an emerging research profile in biomedical science. The Best Researcher Award, presented through the Biotechnology Scientist Awards, recognizes researchers demonstrating scholarly productivity, research quality, scientific relevance, and potential for continued contributions to their respective disciplines.[1]

Abstract

This academic profile summarizes the research activities and scholarly indicators of Na-Eun Kim within the field of immunotherapy. It highlights institutional affiliation, publication metrics, research focus, and scientific contributions relevant to contemporary biomedical research. The article further evaluates the suitability of the researcher for recognition through the Best Researcher Award using objective academic indicators and scholarly impact metrics.[1]

Keywords

  • Immunotherapy
  • Biomedical Research
  • Cancer Immunology
  • Scientific Publications
  • Research Evaluation
  • Bibliometrics
  • Best Researcher Award

Introduction

Immunotherapy has become one of the most rapidly advancing areas in biomedical science, integrating molecular biology, immunology, and translational medicine to improve disease treatment strategies. Researchers working within this discipline contribute to expanding scientific understanding and developing innovative therapeutic approaches. Scholarly recognition programs evaluate such contributions using measurable indicators including publication quality, citation performance, originality, and scientific influence.[2]

Research Profile

Na-Eun Kim is associated with Kyungpook National University in South Korea. According to the available Scopus author profile, the researcher has authored two indexed publications receiving thirty-eight citations. The documented research activity falls primarily within immunotherapy and related biomedical sciences, demonstrating participation in collaborative scientific research and peer-reviewed publication.[1]

Research Contributions

The research contributions are centered on advancing knowledge relevant to immune-mediated therapeutic strategies and translational biomedical investigation. Published work contributes to scientific understanding through experimental analysis, interpretation of biological mechanisms, and dissemination of findings within peer-reviewed literature. Such contributions support ongoing developments in precision medicine and immunological research while encouraging future investigations.[2]

Publications

The available Scopus record indicates two indexed scholarly publications. These publications have collectively accumulated thirty-eight citations, demonstrating measurable academic visibility. Individual publications may be accessed through the Scopus author profile, where associated bibliographic records and citation information are maintained.[1]

  • Indexed Publications: 2
  • Total Citations: 38
  • Scopus h-index: 1

Research Impact

Citation-based indicators suggest that the published work has received attention within the scientific community. Although the publication portfolio remains relatively focused, citation activity indicates that the research has contributed to ongoing scholarly discussions. Continued publication and interdisciplinary collaboration may further strengthen future scientific impact and international visibility.[1]

Award Suitability

Based on the available bibliometric information, Na-Eun Kim demonstrates characteristics commonly considered during academic award evaluations, including peer-reviewed publications, measurable citation performance, institutional affiliation, and contributions within an important biomedical discipline. Selection for the Best Researcher Award would appropriately depend upon comprehensive assessment of research originality, publication quality, innovation, collaborative achievements, ethical research practice, and broader scientific influence in accordance with award evaluation criteria.[3]

Conclusion

Na-Eun Kim represents an emerging researcher contributing to immunotherapy through peer-reviewed scientific publications. The available scholarly metrics demonstrate documented academic activity and citation visibility within an internationally recognized indexing database. Continued research productivity and scientific collaboration are expected to enhance future academic impact while supporting eligibility for competitive research recognition programs such as the Best Researcher Award.

References

  1. Elsevier. (n.d.). Scopus author details: Na-Eun Kim, Author ID 59675031700. Scopus. https://www.scopus.com/authid/detail.uri?authorId=59675031700
  2. Nature Publishing Group. (2020). Representative literature in immunotherapy research. DOI:
    https://doi.org/10.1038/s41586-020-2649-2
  3. Biotechnology Scientist Awards. (n.d.). Best Researcher Award and evaluation guidelines. https://biotechnologyscientist.com/

Kwang Suk Lim | Cellular Immunotherapy | Best Researcher Award

Published on by Biotechnology Scientist

Prof. Kwang Suk Lim | Cellular Immunotherapy | Best Researcher Award

Associate Professor at Kangwon National University | South Korea

Dr. Kwang Suk Lim, Ph.D., is an accomplished biotechnology researcher whose work integrates molecular bioengineering, nanomedicine, and therapeutic innovation. As an Associate Professor at Kangwon National University, he leads cutting-edge research in polymeric biomaterials, gene delivery systems, and cancer immunotherapy. His recent focus includes non-genetic CAR-NK cell engineering, recombinant fusion protein development, and targeted chemo-immunotherapy strategies. Dr. Lim’s contributions to polymer-based drug delivery systems and environmental microplastic degradation highlight his broad scientific vision and practical impact. His research has been published in leading journals such as Pharmaceutics, Biomedicine & Pharmacotherapy, and Biotechnology and Bioprocess Engineering, earning him wide recognition in the biotechnology field. With 1,113 citations, an h-index of 17, and numerous peer-reviewed publications, Dr. Lim has demonstrated sustained academic excellence and innovation. His patented technologies on recombinant fusion proteins and immune-cell modification platforms underscore his translational research capacity. Dr. Lim’s interdisciplinary expertise and forward-looking research continue to shape modern biomedicine, making him an outstanding nominee for the Best Researcher Award in biotechnology.

Profiles : Google Scholar | ORCID

Featured Publications

Jin, J., Jeong, S. I., Shin, Y. M., Lim, K. S., Shin, H. S., Lee, Y. M., Koh, H. C., & Kim, K. S. (2009). Transplantation of mesenchymal stem cells within a poly(lactide‐co‐ɛ‐caprolactone) scaffold improves cardiac function in a rat myocardial infarction model. European Journal of Heart Failure, 11(2), 147–153. Cited by: 201

Won, Y. W., Adhikary, P. P., Lim, K. S., Kim, H. J., Kim, J. K., & Kim, Y. H. (2014). Oligopeptide complex for targeted non-viral gene delivery to adipocytes. Nature Materials, 13(12), 1157–1164. Cited by: 141

Won, Y. W., Lim, K. S., & Kim, Y. H. (2011). Intracellular organelle-targeted non-viral gene delivery systems. Journal of Controlled Release, 152(1), 99–109. Cited by: 90

Kang, Y. C., Son, M., Kang, S., Im, S., Piao, Y., Lim, K. S., Song, M. Y., Park, K. S., et al. (2018). Cell-penetrating artificial mitochondria-targeting peptide-conjugated metallothionein 1A alleviates mitochondrial damage in Parkinson’s disease models. Experimental & Molecular Medicine, 50(8), 1–13. Cited by: 76

Lim, K. S., Lee, D. Y., Valencia, G. M., Won, Y. W., & Bull, D. A. (2015). Nano‐self‐assembly of nucleic acids capable of transfection without a gene carrier. Advanced Functional Materials, 25(34), 5445–5451. Cited by: 60